Sialic acid functions in enterovirus 70 binding and infection

Journal of Virology

Volumn 76, Issue 22, 2002, Pages 11265-11272

  Alexander, David A ^a   Dimock, Kenneth ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DECAY ACCELERATING FACTOR; GLYCOLIPID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYPEPTIDE; SIALIC ACID; SIALIDASE; TUNICAMYCIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; ENTEROVIRUS; ENTEROVIRUS 70; EYE INFECTION; GLYCOSYLATION; HELA CELL; HEMORRHAGIC CONJUNCTIVITIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; NUCLEOTIDE SEQUENCE; PICORNAVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD55; CELL LINE; CRICETINAE; ENTEROVIRUS D, HUMAN; GLYCOSYLATION; HUMANS; IMMUNOBLOTTING; MICE; MUTAGENESIS, SITE-DIRECTED; NEURAMINIDASE; SIALIC ACIDS;

EID: 0036827625     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.22.11265-11272.2002     Document Type: Article

References (51)

1. v integrins. J. Virol. 74:7691-7693.
2. Barton, E. S., J. L. Connolly, J. C. Forrest, J. D. Chappell, and T. S. Dermody. 2001. Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J. Biol. Chem. 276:2200-2211.
3. Barton, E. S., J. C. Forrest, J. L. Connolly, J. D. Chappell, Y. Liu, F. J. Schnell, A. Nusrat, C. A. Parkos, and T. S. Dermody. 2001. Junction adhesion molecule is a receptor for reovirus. Cell 104:441-451.
4. Bauer, P. H., C. Cui, T. Stehle, S. C. Harrison, J. A. DeCaprio, and T. L. Benjamin. 1999. Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse. J. Virol. 73:5826-5832.
5. Bergelson, J. M., M. Chan, K. R. Solomon, N. F. St. John, H. Lin, and R. W. Finberg. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. USA 91:6245-6249.
6. Bergelson, J. M., J. F. Modlin, W. Wieland-Alter, J. A. Cunningham, R. L. Crowell, and R. W. Finberg. 1997. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J. Infect. Dis. 175:697-700.
7. Clarkson, N. A., R. Kaufman, D. M. Lublin, T. Ward, P. A. Pipkin, P. D. Minor, D. J. Evans, and J. W. Almond. 1995. Characterization of the echovirus 7 receptor: Domains of CD55 critical for virus binding. J. Virol. 69:5497-5501.
8. Connolly, J. L., E. S. Barton, and T. S. Dermody. 2001. Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J. Virol. 75:4029-4039.
9. Coyne, K. E., S. E. Hall, S. Thompson, M. A. Arce, T. Kinoshita, T. Fujita, D. J. Anstee, W. Rosse, and D. M. Lublin. 1992. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J. Immunol. 149:2906-2913.
10. Duksin, D., and W. C. Mahoney. 1982. Relationship of the structure and biological activity of the natural homologues of tunicamycin. J. Biol. Chem. 257:3105-3109.
11. Evans, D. J., and J. W. Almond. 1998. Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis. Trends Microbiol. 6:198-202.
12. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
13. Higgins, P. G. 1982. Enteroviral conjunctivitis and its neurological complications. Arch. Virol. 73:91-101.
14. Jentoft, N. 1990. Why are proteins O-glycosylated? Trends Biochem. Sci. 15:291-294.
15. Jin, Y. M., I. U. Pardoe, A. T. Burness, and T. I. Michalak. 1994. Identification and characterization of the cell surface 70-kilodalton sialoglycoprotein(s) as a candidate receptor for encephalomyocarditis virus on human nucleated cells. J. Virol. 68:7308-7319.
16. Kaludov, N., K. E. Brown, R. W. Walters, J. Zabner, and J. A. Chiorini. 2001. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75:6884-6893.
17. Karnauchow, T. M., S. Dawe, D. M. Lublin, and K. Dimock. 1998. Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding. J. Virol. 72:9380-9383.
18. Karnauchow, T. M., D. L. Tolson, B. A. Harrison, E. Altman, D. M. Lublin, and K. Dimock. 1996. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J. Virol. 70:5143-5152.
19. Krempl, C., M. L. Ballesteros, G. Zimmer, L. Enjuanes, H. D. Klenk, and G. Herrler. 2000. Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants. J. Gen. Virol. 81:489-496.
20. Kuan, S. F., J. C. Byrd, C. Basbaum, and Y. S. Kim. 1989. Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. J. Biol. Chem. 264:19271-19277.
21. Lea, S. M., R. M. Powell, T. McKee, D. J. Evans, D. Brown, D. I. Stuart, and P. A. van der Merwe. 1998. Determination of the affinity and kinetic constants for the interaction between the human virus echovirus 11 and its cellular receptor, CD55. J. Biol. Chem. 273:30443-30447.
22. Lublin, D. M., and J. P. Atkinson. 1989. Decay-accelerating factor: Biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7:35-58.
23. Lublin, D. M., J. Krsek-Staples, M. K. Pangburn, and J. P. Atkinson. 1986. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor. J. Immunol. 137:1629-1635.
24. Maitreyi, R. S., L. Dar, A. Muthukumar, M. Vajpayee, I. Xess, R. B. Vajpayee, P. Seth, and S. Broor. 1999. Acute hemorrhagic conjunctivitis due to enterovirus 70 in India. Emerg. Infect. Dis. 5:267-269.
25. Medof, M. E., D. M. Lublin, V. M. Holers, D. J. Ayers, R. R. Getty, J. F. Leykam, J. P. Atkinson, and M. L. Tykocinski. 1987. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. USA 84:2007-2011.
26. Medof, M. E., E. I. Walter, J. L. Rutgers, D. M. Knowles, and V. Nussenzweig. 1987. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J. Exp. Med. 165:848-864.
27. Mendez, E., S. Lopez, M. A. Cuadras, P. Romero, and C. F. Arias. 1999. Entry of rotaviruses is a multistep process. Virology 263:450-459.
28. Nowicki, B., A. Hart, K. E. Coyne, D. M. Lublin, and S. Nowicki. 1993. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J. Exp. Med. 178:2115-2121.
29. Powell, R. M., V. Schmitt, T. Ward, I. Goodfellow, D. J. Evans, and J. W. Almond. 1998. Characterization of echoviruses that bind decay accelerating factor (CD55): Evidence that some haemagglutinating strains use more than one cellular receptor. J. Gen. Virol. 79:1707-1713.
30. Powell, R. M., T. Ward, D. J. Evans, and J. W. Almond. 1997. Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): Evidence for a secondary cellular factor in A-particle formation. J. Virol. 71:9306-9312. (Erratum, 72:890, 1998.)
31. Powell, R. M., T. Ward, I. Goodfellow, J. W. Almond, and D. J. Evans. 1999. Mapping the binding domains on decay accelerating factor (DAF) for haem-agglutinating enteroviruses: Implications for the evolution of a DAF-binding phenotype. J. Gen. Virol. 80:3145-3152.
32. Savolainen, C., S. Blomqvist, M. N. Mulders, and T. Hovi. 2002. Genetic clustering of all 102 human rhinovirus prototype strains: Serotype 87 is close to human enterovirus 70. J. Gen. Virol. 83:333-340.
33. Schmidtke, M., H. C. Selinka, A. Heim, B. Jahn, M. Tonew, R. Kandolf, A. Stelzner, and R. Zell. 2000. Attachment of coxsackievirus B3 variants to various cell lines: Mapping of phenotypic differences to capsid protein VP1. Virology 275:77-88.
34. Schneider-Schaulies, J. 2000. Cellular receptors for viruses: Links to tropism and pathogenesis. J. Gen. Virol. 81:1413-1429.
35. Shafren, D. R., R. C. Bates, M. V. Agrez, R. L. Herd, G. F. Burns, and R. D. Barry. 1995. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 69:3873-3877.
36. Shafren, D. R., D. J. Dorahy, R. A. Ingham, G. F. Burns, and R. D. Barry, 1997. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J. Virol. 71:4736-4743.
37. Shafren, D. R., D. T, Williams, and R. D. Barry. 1997. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J. Virol. 71:9844-9848.
38. Shulman, L. M., Y. Manor, R. Azar, R. Handsher, A. Vonsover, E. Mendelson, S. Rothman, D. Hassin, T. Halmut, B. Abramovitz, and N. Varsano. 1997. Identification of a new strain of fastidious enterovirus 70 as the causative agent of an outbreak of hemorrhagic conjunctivitis. J. Clin. Microbiol. 35:2145-2149.
39. Spiller, O. B., I. G. Goodfellow, D. J. Evans, J. W. Almond, and B. P. Morgan. 2000. Echoviruses and coxsackie B viruses that use human decayaccelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF. J. Infect. Dis. 181:340-343.
40. Spillmann, D. 2001. Heparan sulfate: Anchor for viral intruders? Biochimie 83:811-817.
41. Stoner, G. D., B. Williams, A. Kniazeff, and M. B. Shimkin. 1973. Effect of neuraminidase pretreatment on the susceptibility of normal and transformed mammalian cells to bovine enterovirus 261. Nature 245:319-320.
42. Suzuki, T., A. Portner, R. A. Scroggs, M. Uchikawa, N. Koyama, K. Matsuo, Y. Suzuki, and T. Takimoto. 2001. Receptor specificities of human respiroviruses. J. Virol. 75:4604-4613.
43. Suzuki, Y., T. Ito, T. Suzuki, R. E. Holland, Jr., T. M. Chambers, M. Kiso, H. Ishida, and Y. Kawaoka. 2000. Sialic acid species as a determinant of the host range of influenza A viruses. J. Virol. 74:11825-11831.
44. Uchio, E., K. Yamazaki, H. Ishikawa, I. Matsunaga, Y. Asato, K. Aoki, and S. Ohno. 1999. An epidemic of acute haemorrhagic conjunctivitis caused by enterovirus 70 in Okinawa, Japan, in 1994. Graefe's Arch. Clin. Exp. Ophthalmol. 237:568-572.
45. Uncapher, C. R., C. M. DeWitt, and R. J. Colonno. 1991. The major and minor group receptor families contain all but one human rhinovirus serotype. Virology 180:814-817.
46. Utagawa, E. T., K. Miyamura, A. Mukoyama, and R. Kono. 1982. Neuraminidase-sensitive erythrocyte receptor for enterovirus type 70. J. Gen. Virol. 63:141-148.
47. Wairagkar, N. S., S. S. Gogate, and A. S. Labhsetwar. 1999. Investigation of an epidemic of acute haemorrhagic conjunctivitis in Pune, India. J. Commun. Dis. 31:41-43.
48. Ward, T., P. A. Pipkin, N. A. Clarkson, D. M. Stone, P. D. Minor, and J. W. Almond. 1994. Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J. 13:5070-5074.
49. Wright, P. W., G. H. Strauss, and M. P. Langford. 1992. Acute hemorrhagic conjunctivitis. Am. Fam. Physician 45:173-178.
50. Yoshii, T., K. Natori, and R. Kono. 1977. Replication of enterovirus 70 in non-primate cell cultures. J. Gen. Virol. 36:377-384.
51. Zhou, L., Y. Luo, Y. Wu, J. Tsao, and M. Luo. 2000. Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J. Virol. 74:1477-1485.